EUVIMEDEUVIMED entdecken
Crossref

Pharmacological inhibition of histone deacetylase alleviates chronic unpredictable stress induced atherosclerosis and endothelial dysfunction via upregulation of BDNF

Mujeeba Rehman, Vipul Agarwal, Rishabh Chaudhary, Arjun Singh Kaushik, Siddhi Srivastava, Sukriti Srivastava, Anand Kumar, Sanjay Singh, Vikas Mishra

Biochemical and Biophysical Research Communications · 2024-11 · 735 · 150485

DOI: 10.1016/j.bbrc.2024.150485 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024-11. Verfasst von Mujeeba Rehman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow, Uttar Pradesh, 226025, India. Hauptthemen laut MEDLINE: Atherosclerosis, Brain-Derived Neurotrophic Factor, Endothelium, Vascular, Histone Deacetylase Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 154 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-term stress is a significant risk factor for cardiovascular diseases, including atherosclerosis and endothelial dysfunction. Moreover, prolonged stress has shown to negatively regulate central BDNF expression. The role of central BDNF in CNS disorders is well studied until recently the peripheral BDNF was also found to be involved in endothelial function regulation and atherosclerosis. The peripheral BDNF and its role in chronic stress-induced atherosclerosis and endothelial dysfunction remain unclear. Therefore, we aimed to elucidate the role of BDNF and its modulation by the HDAC inhibitor valproic acid (VA) in chronic unpredictable stress (CUS)-induced atherosclerosis and endothelial dysfunction. We demonstrated that a 10-week CUS mouse model substantially decreases central and peripheral BDNF expression, resulting in enhanced serum lipid indices, plaque deposition, fibrosis, and CD68 expression in thoracic aortas. Further, parameters associated with endothelial dysfunction such as increased levels of endothelin-1 (ET-1), adhesion molecules like VCAM-1, M1 macrophage markers, and decreased M2 macrophage markers, eNOS expression, and nitrite levels in aortas, were also observed. VA (50 mg/kg, 14 days, i. p.) was administered to mice following 8 weeks of CUS exposure until the end of the experimental procedure. VA significantly prevented the decrease in BDNF, eNOS and nitrite levels, reduced lesion formation and fibrosis in thoracic aortas and increased ET-1, and VCAM-1 followed by M2 polarization in VA-treated mice. The study highlights the potential of epigenetic modulation of BDNF as a therapeutic target, in stress-induced cardiovascular pathologies and suggests that VA could be a promising agent for mitigating CUS-induced endothelial dysfunction and atherosclerosis by BDNF modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisBrain-Derived Neurotrophic FactorEndothelium, VascularHistone Deacetylase InhibitorsUp-RegulationValproic AcidAnimalsMaleMiceAorta, ThoracicEndothelin-1Mice, Inbred C57BLNitric Oxide Synthase Type IIIStress, PsychologicalVascular Cell Adhesion Molecule-1

Stichwörter der Autor:innen

AtherosclerosisBDNFChronic unpredictable stressEndothelial dysfunctionHistone deacetylaseValproic acid

Substanzen

Bdnf protein, mouseBrain-Derived Neurotrophic FactorEndothelin-1Histone Deacetylase InhibitorsNitric Oxide Synthase Type IIIValproic AcidVascular Cell Adhesion Molecule-1

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow, Uttar Pradesh, 226025, India.
  • Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow, Uttar Pradesh, 226025, India. Electronic address: ssingh.phe@itbhu.ac.in.
  • Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow, Uttar Pradesh, 226025, India. Electronic address: vikasmishra12@gmail.com.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Rehman, M., Agarwal, V., Chaudhary, R., Kaushik, A. S., Srivastava, S., Srivastava, S., Kumar, A., Singh, S., & Mishra, V. (2024). Pharmacological inhibition of histone deacetylase alleviates chronic unpredictable stress induced atherosclerosis and endothelial dysfunction via upregulation of BDNF. Biochemical and Biophysical Research Communications, 735, 150485. https://doi.org/10.1016/j.bbrc.2024.150485

Vancouver

Rehman M, Agarwal V, Chaudhary R, Kaushik AS, Srivastava S, Srivastava S, et al. Pharmacological inhibition of histone deacetylase alleviates chronic unpredictable stress induced atherosclerosis and endothelial dysfunction via upregulation of BDNF. Biochemical and Biophysical Research Communications. 2024;735:150485. doi:10.1016/j.bbrc.2024.150485

BibTeX
@article{Rehman2024,
  author = {Rehman, Mujeeba and Agarwal, Vipul and Chaudhary, Rishabh and Kaushik, Arjun Singh and Srivastava, Siddhi and Srivastava, Sukriti and Kumar, Anand and Singh, Sanjay and Mishra, Vikas},
  title = {Pharmacological inhibition of histone deacetylase alleviates chronic unpredictable stress induced atherosclerosis and endothelial dysfunction via upregulation of BDNF},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  volume = {735},
  pages = {150485},
  doi = {10.1016/j.bbrc.2024.150485}
}
Kostenlos starten →